awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35060360-BA952F2D-C790-47DD-96DA-F0463F08F739
Q35060360-BA952F2D-C790-47DD-96DA-F0463F08F739
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35060360-BA952F2D-C790-47DD-96DA-F0463F08F739
Comparative role of intravitreal ranibizumab versus bevacizumab in choroidal neovascular membrane in age-related macular degeneration
P2860
Q35060360-BA952F2D-C790-47DD-96DA-F0463F08F739
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35060360-BA952F2D-C790-47DD-96DA-F0463F08F739
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dda17faa3a4f4e2ce018783deca04667ea9eea7e
P2860
Comparative study of intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) in the treatment of neovascular age-related macular degeneration.